Trial Details
COMPLETEDBasic Information
| Clinical ID | c1492 |
|---|---|
| Identifier | NCT00808977 |
| Trial Title | A Phase II Study to Explore the Safety and Activity of Dersalazine in Patients With Mild to Moderate Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Dersalazine sodium|DRUG: Mesalazine|DRUG: Placebo |
Participant Information
| Sponsor | Palau Pharma S.L.U. |
|---|---|
| City | Kortrijk |
| Country/Region | Belgium |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2025-12-08 |
|---|---|
| Primary Completion Date | 2025-06-10 |
| Completion Date | 2025-06-10 |